Author

C. H. Dumard

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. M. O. Gomes· 3 shared J. L. Silva· 3 shared A. C. Oliveira· 2 shared A. Tanuri· 2 shared F. F. Marsili· 2 shared H. L. de Matos Guedes· 2 shared R. G. F. Alvim· 2 shared T. M. L. Souza· 2 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

A. M. O. Gomes

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Immunogenicity of SARS-CoV-2 trimetric spike protein associated to Poly(I:C) plus Alum

J. d. Santos, L. F. Cruz, A. M. d. Fonseca-Martins, D. O. Maciel, G. G. Perez, V. A. Roncaglia-Pereira, C. H. Dumard, F. H. Guedes da Silva, A. C. V. dos Santos, M. S. Leandro, J. R. M. Ferreira, K. G. Pinto, L. Conde, D. A. S. Rodrigues, M. V. M. Silva, , H. L. de Matos Guedes

This study evaluates a vaccine strategy using Alum and Poly(I:C) adjuvants with SARS-CoV-2 spike protein, showing enhanced antibody and T-cell responses and reduced lung inflammation.

bioRxiv · Oct 5, 2021 · PreprintImmunology

Potent neutralizing equine antibodies raised against recombinant SARS-CoV-2 spike protein for COVID-19 passive immunization therapy

L. E. R. Cunha, A. A. Stolet, M. A. Strauch, V. A. R. Pereira, C. H. Dumard, A. M. O. Gomes, P. N. C. Souza, J. G. Fonseca, F. E. Pontes, L. G. R. Meirelles, J. W. M. Albuquerque, C. Q. Sacramento, N. Fintelman-Rodrigues, T. M. Lima, R. G. F. Alvim, , J. L. Silva

This study produces potent equine antibodies against SARS-CoV-2 spike protein with high neutralizing titers, supporting a clinical trial for passive immunization therapy.

bioRxiv · Aug 17, 2020 · PreprintImmunology

Yellow Fever Vaccine Protects Resistant and Susceptible Mice Against Zika Virus Infection

A. C. Vicente Santos, F. H. Guedes-da-Silva, C. H. Dumard, V. N. S. Ferreira, I. P. S. da Costa, R. A. Machado, F. G. Q. Barros-Aragao, R. L. S. Neris, J. S. Dos-Santos, I. Assuncao-Miranda, C. P. Figueiredo, A. A. Dias, A. M. O. Gomes, H. L. de Matos Guedes, A. C. Oliveira, J. L. Silva

This study shows that the yellow fever vaccine (17DD) protects both resistant and susceptible mice against Zika virus infection, reducing mortality, viral load, and neurological impairment.

bioRxiv · Mar 29, 2019 · PreprintImmunology